ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532296 announcements Glenmark Pha announcements and dividends declared BSE

Glenmark Pha Complete list of announcements declared & dividend announcements by Glenmark Pha 532296

Glenmark Pha 532296 listed on BSE and deals in

Announcements and dividends declared by Glenmark Pha 532296

Eris Lifesciences to buy some dermatology brands from Glenmark Pharma
The deal for the portfolio that has an annual revenue base of 850 million rupees, will be financed through borrowings, and the transaction is expected to achieve financial closure very soon, Eris said
Announcement as on 17 January 2023

Glenmark Pharmaceuticals launches generic version of diuretic Bumetanide injection
The launch affirms commitment to Glenmark's continued focus on institutional business, company Senior Vice President, Business Development Portfolio, Product Launch & Strategy, Vijay Raghavan said. The Bumex injection, 0.25 mg/mL achieved annual sales of a
Announcement as on 10 January 2023

F&O Call: Nandish Shah recommends to long Glenmark Pharma futures
The derivative analyst from HDFC Securities expects Glenmark Pharma January futues to test Rs 450 on the upside.
Announcement as on 06 January 2023

Glenmark Pharmaceuticals rises 5% on launching first 3-drug FDC for type-2 diabetes in India
“This FDC has been launched under the brand name Zita®-PioMet,” the company said in a BSE filing. “This offers patients with Type 2 diabetes the convenience of once-daily dosing to improve their glycemic control and achieve the targeted HbA1c within
Announcement as on 21 December 2022

Glenmark Pharma launches combination drug for Type 2 diabetic patients
Glenmark Pharmaceuticals Ltd on Wednesday said it has launched triple fixed-dose combination Teneligliptin with Pioglitazone and Metformin in India for diabetic patients. This fixed-dose combination offers patients with Type 2 diabetes the convenience of o
Announcement as on 21 December 2022

Announcements by Glenmark Pha first page | Next page | Prev page |

532296 Glenmark Pha current price & indicator signals

Moving Averages for Glenmark Pha

  • 5Day Average: 2153.06
  • 12Day Average: 2166.72
  • 20Day Average: 2228.6
  • 50Day Average: 2267
  • 100Day Average: 2165.37
  • 150Day Average: 2096.42
  • 200Day Average: 2062.26

532296 Indicators & signals

Indicator MACD (12,26,9)

2180.68, 2221.84, -32.57
Indicator MACD is in negative zone

Indicator ADX (14)

34.9, 10.74, 22.25
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 44
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532296 Glenmark Pha are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
17 Wed Jun 2026 2135.35 2109.00 to 2170.00 -0.99% 0.62 times
16 Tue Jun 2026 2156.80 2133.50 to 2171.55 0.06% 0.76 times
15 Mon Jun 2026 2155.60 2146.00 to 2199.85 -0.81% 0.71 times
12 Fri Jun 2026 2173.20 2118.00 to 2191.80 1.35% 0.65 times
11 Thu Jun 2026 2144.35 2141.00 to 2169.00 0.01% 0.43 times
10 Wed Jun 2026 2144.10 2137.05 to 2251.00 -2.86% 1.84 times
09 Tue Jun 2026 2207.25 2165.00 to 2220.00 1.32% 1.06 times
08 Mon Jun 2026 2178.55 2132.80 to 2206.00 0.6% 0.64 times
05 Fri Jun 2026 2165.50 2160.60 to 2215.00 -0.73% 2.15 times
04 Thu Jun 2026 2181.45 2147.00 to 2207.10 0.36% 0.51 times
03 Wed Jun 2026 2173.55 2147.10 to 2221.35 -0.52% 1.26 times
02 Tue Jun 2026 2184.90 2144.40 to 2239.45 -0.74% 1.46 times

Videos related to: 532296 announcements Glenmark Pha announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

532296 announcements Glenmark Pha announcements and dividends declared BSE

 

Back to top